-
First sound pharmaceutical industry to Hong Kong stock exchange listing, 3 key products are expected to be listed in the next two years!
Time of Update: 2020-06-16
The latest announcement of the Hong Kong Stock Exchange indicates that First Sound Pharmaceuticals has submitted an application for listing in accordance with Section 8.12 of the Listing Rules Accord
-
Collection: June 4, 2020 Blood Research Picks
Time of Update: 2020-06-16
Hematopoietic cell transplantation treatment Wiskott-Aldrich syndrome is a prognostic Aldrich syndrome (WAS) is an X-chromosome chain disease caused by mutations in the WAS gene that can lead to plat
-
Blood: New demethylation drug OR-2100 targets treatment of DNA abnormal supermethylation-driven ATL leukemia
Time of Update: 2020-06-16
Adult T-cell leukemia - lymphoma (ATL) is an invasive CD4-T cell blood tumor transformed by human T-cell lymphatic virus-1 (HTLV-1) Most individuals infected with HTLV-1 are asymptomatic, and only 3-
-
Nature: Tumor metabolites disrupt chromatin signals and inhibit DNA repair
Time of Update: 2020-06-16
Metabolic disorders and the destruction of genomic integrity are the main markers of cancer Increased levels of metabolites 2-hydroxypronoric acid, semacid and fumatate are found in human malignancie
-
FDA: Approves second-line treatment of navulyo monoantine approved esophageal squamous cancer
Time of Update: 2020-06-16
Esophageal cancer is a common digestive tumor, compared with Europe and the United States, the incidence of esophageal cancer in China is higher, and has a certain degree of regional differences Euro
-
Example: Analysis of expression differences between cancer and cancer-side tissue using TCGA database
Time of Update: 2020-06-16
Example: How to analyze the expression difference between LINC00152 in ovarian cancer and normal tissue using the TCGA database? So with this topic as a record analysis process as follows: First, dow
-
CD20xCD3 bispecific antibodies! Roche glofitamab treatment for recurrent/refractive non-Hodgkin's lymphoma (NHL) shows strong results!
Time of Update: 2020-06-16
JUNE 14, 2020 /PRNewswire/ -- Roche recently released the latest data on CD20xCD3 T cells binding bispecific antibody glofitamab (formerly known as CD20-TCB) for recurrent or refractive (R)non-Hodgkin
-
Blood: JAK/STAT signal suppression enhances the sensitivity of CD8 T cells to dexamethasone-induced apoptosis
Time of Update: 2020-06-16
Cytokine storm syndrome (CSS) is a severe hyper-inflammatory state characterized by overactivation of the immune system, which can lead to organ damage and patient death Phytopha lymphatic tissue cyt
-
Lancet oncol: Clinical characteristics and risk factors for cancer patients infected with the new coronavirus in Wuhan
Time of Update: 2020-06-16
COVID-19 has spread around the world Cancer patients are reported to be epidemiologically sensitive to the new coronavirus The purpose of this study is to systematically describe the clinical charact
-
Take stock: A selection of Blood Research Highlights of June 11, 2020
Time of Update: 2020-06-16
Transcription factor ATF4 activation BCL11A transcription to silent fetal hemoglobin expression Fetal hemoglobin reactivation remains a critical goal for the treatment of patients with sickle cell di
-
Blood: Talin1 is the main Rap1 effector for platelet integration activation
Time of Update: 2020-06-16
Rap1 is the main convergence point of platelet signaling pathway, regulating the combination of talin1 and integrated b cytoplasmic domain, thus activating the integrated hormone, promoting platelet
-
Lancet oncol: Mortality after breast malignancy infection with COVID-19
Time of Update: 2020-06-16
Early reports of COVID-19 cancer patients suggest that cancer patients with COVID-19 had a higher mortality rate than the general population Given the age of patients with chest cancer, smoking habit
-
Nature: Key Targets for Neutrophils To Promote Breast Cancer Metastasis Found - CCDC25
Time of Update: 2020-06-16
Neutrophils are immune cells that provide the body with the first line of defense against infection However, in many cases, neutrophils also have the ability to promote cell cell metastasis In a new
-
Professor Li Jin's own account: a conscience can become a good doctor
Time of Update: 2020-06-16
Since i have become a doctor, this life to save people is my job, but also the source of my life, nothing else Although the World Health Organization has long defined cancer as a chronic disease, the
-
Blood: Effects of DHFR and FPGS germ cell mutations on methotrexate metabolism and RISK OF ALL recurrence
Time of Update: 2020-06-16
Methotrexate (MTX) maintenance therapy is critical for the treatment of acute lymphoblastic leukemia (ALL), but achieving appropriate treatment doses with individual differences remains a challenge w
-
What dose is appropriate for elderly and infirm lung cancer patients?
Time of Update: 2020-06-16
In the International Journal of Cancer, European Journal of Cancer and other published SCI papers 65, the cumulative impact factor of about 300 points, of which the first or the first author of THE S
-
Co-develop bispecific antibodies! AbbVie's $750 million advance to Genmab
Time of Update: 2020-06-16
The two companies announced that AbbVie will make a $750 million advance payment to Genmab as part of a partnership to jointly develop and commercialize three next-generation bispecific antibodies Th
-
A major breakthrough in science! A lot of bacteria were found in the tumor!
Time of Update: 2020-06-16
How do they promote or hinder the growth of cancer?
What are their effects on the response to various cancer treatments?
-
PNAS: New engineered protein seq.com blocks cancer from growing and regenerating neurons
Time of Update: 2020-06-16
Ligands are protein molecules that transmit signals between or within cells Ligands work by binding to a cell protein called a receptor After binding to the ligand, the receptor can send additional s
-
Ann Oncol: OlympiAD's final overall survival and tolerance results
Time of Update: 2020-06-16
In the OlympiAD study, olapani was shown to improve progressive survival metastatic breast cancer (mBC) compared to chemotherapy with a reproductive BRCA1 and/or BRCA2 mutation (BRCAAm) and a human e